5/12/2009

The Academy of Molecular Imaging has started patient enrollment for a clinical study that will compare traditional planar technetium-99m methylene diphosphonate bone imaging with F-18 NaF PET/CT in detecting bone metastases. The trial will involve about 500 patients with breast, prostate and nonsmall cell lung cancers.

Related Summaries